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Psoriasis is a common chronic inflammatory skin dis-
ease with a prevalence of about 2% in the Caucasian
population. Tumor necrosis factor (TNF) plays an
essential role in the pathogenesis of psoriasis, but
its mechanism of action remains poorly understood.
Here we report that the development of psoriasis-like
skin inflammation in mice with epidermis-specific
inhibition of the transcription factor NF-kB was
triggered by TNF receptor 1 (TNFR1)-dependent
upregulation of interleukin-24 (IL-24) and activation
of signal transducer and activator of transcrip-
tion 3 (STAT3) signaling in keratinocytes. IL-24 was
strongly expressed in human psoriatic epidermis,
and pharmacological inhibition of NF-kB increased
IL-24 expression in TNF-stimulated human primary
keratinocytes, suggesting that this mechanism is
relevant for human psoriasis. Therefore, our results
expand current views on psoriasis pathogenesis by
revealing a new keratinocyte-intrinsic mechanism
that links TNFR1, NF-kB, ERK, IL-24, IL-22R1, and
STAT3 signaling to disease initiation.
INTRODUCTION
The skin forms an essential structural and immunological barrier
protecting the organism from water loss and from mechanical,Ichemical, and microbial challenges. A tightly regulated cross-
talk between epithelial, mesenchymal, and immune cells is
essential for both themaintenance of a healthy skin homeostasis
and its reestablishment after injury. Disruption of skin homeosta-
sis results in chronic inflammatory skin diseases such as psoria-
sis. Psoriatic skin inflammation evolves through interactions
between epidermal keratinocytes and cells of the immune sys-
tem (Nestle et al., 2009). Although the immune mechanisms
contributing to cutaneous inflammation in psoriatic skin have
been extensively characterized, the factors responsible for trig-
gering the initiation of skin inflammation are not known. Although
it is generally believed that T lymphocytes and dendritic cells
contribute to its pathogenesis in an essential manner (Lowes
et al., 2005; Nickoloff and Wrone-Smith, 1999), the contribution
of epidermal keratinocytes to the onset of psoriasis remains
poorly understood.
The efficacy of tumor necrosis factor (TNF)-neutralizing drugs
in the treatment of psoriasis demonstrates an essential role for
TNF in its pathogenesis (Lowes et al., 2007). TNF is a highly
potent proinflammatory cytokine (Apostolaki et al., 2010). The
ubiquitously expressed TNF receptor 1 (TNFR1) mediates the
majority of TNF responses by activating intracellular signaling
cascades inducing inflammation but also cell death (Walczak,
2011). However, the molecular mechanisms responsible for its
pathogenic role and the cellular targets of TNF in psoriasis
remain unknown. More recently, cytokines of the interleukin-10
(IL-10) family, including IL-19, IL-20, IL-22, and IL-24, have
been implicated in the pathogenesis of psoriasis (Kunz et al.,
2006; Leng et al., 2011; Rømer et al., 2003; Weiss et al., 2004;
Wolk et al., 2009a). Increased expression of IL-19, IL-20, IL-22,
and IL-24 was detected in psoriatic compared to normal skinmmunity 39, 899–911, November 14, 2013 ª2013 Elsevier Inc. 899
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TNF-IL-24 Axis in Psoriasis-like Skin Inflammation(Kunz et al., 2006; Rømer et al., 2003; Wang et al., 2012; Weiss
et al., 2004; Wolk et al., 2009b). In the skin, IL-22 is produced
mainly by T cells, whereas IL-19, IL-20, and IL-24 are produced
by keratinocytes, myeloid cells, and T cells (Conti et al., 2003;
Kunz et al., 2006; Zheng et al., 2007). The receptors for IL-19,
IL-20, IL-22, and IL-24 are expressed at high amounts in kerati-
nocytes and signal primarily by activating signal transducer and
activator of transcription 3 (STAT3) (Dumoutier et al., 2001; Kunz
et al., 2006; Parrish-Novak et al., 2002). STAT3 is overexpressed
and activated in lesional psoriatic skin (Sano et al., 2005; Wolk
et al., 2009a), and transgenic expression of constitutively active
STAT3 in epidermal keratinocytes induced psoriasis-like skin
inflammation in mice (Sano et al., 2005), suggesting an important
role for epidermal STAT3 signaling in psoriasis.
We showed previously that nuclear factor kappa B (NF-kB)
inhibition in keratinocytes by deletion of IkB kinase 2 (K14-Cre
Ikk2fl/fl) (Pasparakis et al., 2002) or by transgenic IkBa superre-
pressor expression (K5-IkBaSR) (van Hogerlinden et al., 1999)
triggers inflammatory skin lesions in mice. Histologically detect-
able signs of inflammation appear between postnatal days P3 to
P4 in the epidermis of K14-Cre Ikk2fl/fl mice and rapidly progress
to a severe inflammatory skin condition, resulting in the death of
all animals between P8 andP10. Skin inflammation in K5-IkBaSR
mice starts around 3–4 weeks after birth and progresses more
slowly than in the K14-Cre Ikk2fl/fl mice. The skin lesions induced
by epidermis-specific NF-kB inhibition in these mouse models
closely resemble human psoriasis, both clinically and histologi-
cally. They consist of widespread scaly plaques, which upon
histological analysis show acanthosis, hyperkeratosis, dilation
of dermal blood vessels, and infiltration by a mixed inflammatory
infiltrate with neutrophils forming aggregates in the upper
epidermis (Pasparakis et al., 2002; van Hogerlinden et al.,
1999). Genetic ablation of TNFR1 in the whole body prevents
the development of inflammatory skin lesions in both the K14-
Cre Ikk2fl/fl and theK5-IkBaSRmice (Lind et al., 2004; Pasparakis
et al., 2002), demonstrating that TNF regulates the pathogenesis
of skin inflammation in these models similarly to psoriasis in
humans. Skin inflammation in K14-Cre Ikk2fl/fl mice occurs inde-
pendently of ab T cells but requires the presence of macro-
phages in the dermis (Stratis et al., 2006).
Here we investigated how keratinocyte-intrinsic inhibition of
NF-kB causes psoriasis-like skin inflammation. Our study un-
covers a mechanism that links NF-kB, TNF, IL-24, and STAT3
signaling in epidermal keratinocytes to the initiation of psoria-
sis-like skin inflammation in mice. We also provide evidence
that a similar mechanism could be implicated in the early stages
of the development of skin inflammation in human psoriasis.
RESULTS
TNFR1 in Keratinocytes Triggers Skin Inflammation in
Mice with Epidermis-Specific NF-kB Inhibition
To address whether TNFR1 signaling in epidermal keratinocytes
is needed for the development of skin inflammation in K14-Cre
Ikk2fl/fl mice, the mice were crossed with animals carrying
‘‘floxed’’ TNFR1 alleles to generate mice lacking both IKK2 and
TNFR1 specifically in keratinocytes (K14-Cre Ikk2fl/fl Tnfr1fl/fl).
Flow cytometry analysis of TNFR1 expression confirmed effi-
cient deletion of TNFR1 in epidermal keratinocytes in K14-Cre900 Immunity 39, 899–911, November 14, 2013 ª2013 Elsevier Inc.Ikk2fl/fl Tnfr1fl/fl mice (Figure 1A). In contrast to K14-Cre IKK2fl/fl,
which developed severe skin inflammation shortly after birth
and died before P9 (Pasparakis et al., 2002), K14-Cre Ikk2fl/fl
Tnfr1fl/fl mice appeared macroscopically normal and reached
adulthood without showing inflammatory skin lesions, similar to
K14-Cre Ikk2fl/fl mice with ubiquitous deletion of TNFR1 (K14-
Cre Ikk2fl/fl Tnfr1/) (data not shown). Histological analysis
revealed normal epidermal thickness and differentiation and
absence of inflammatory infiltrates from the skin of K14-Cre
Ikk2fl/fl Tnfr1fl/fl mice (Figures 1B and 1C). These results demon-
strate that TNFR1 signaling in keratinocytes is essential for the
pathogenesis of the inflammatory skin disease in this model.
To address whether TNFR1 expression in keratinocytes was
sufficient to induce skin inflammation in K14-Cre Ikk2fl/fl mice,
we employed the TNFR1cneo mouse model, in which the expres-
sion of TNFR1 is disrupted by insertion of a loxP-flanked neo
cassette in intron 5 of the Tnfr1 gene (Victoratos et al., 2006).
By crossing K14-Cre Ikk2fl/fl with Tnfr1cneo mice we generated
K14-Cre Ikk2fl/fl animals expressing TNFR1 exclusively in
epidermal keratinocytes (K14-Cre Ikk2fl/fl Tnfr1cneo/cneo mice)
(see Figure S1A available online). These animals macroscopi-
cally displayed milder skin lesions at P7 compared to K14-Cre
Ikk2fl/fl mice, which progressively developed to severe skin
inflammation by the age of 4 weeks (data not shown). Histolog-
ical analysis revealed epidermal hyperplasia and inflammation
in the skin of K14-Cre Ikk2fl/fl Tnfr1cneo/cneo mice at P7 (Figure 1B;
Figure S1B), demonstrating that TNFR1 expression in keratino-
cytes was sufficient to trigger skin inflammation in K14-Cre
Ikk2fl/fl mice.
To address the role of epidermal TNFR1 signaling in the K5-Ik
BaSR model, we generated transgenic mice expressing mouse
TNFR1 under the control of the keratin 5 promoter and crossed
them to K5-IkBaSR Tnfr1/ mice. The resulting K5-IkBaSR
Tnfr1/ K5-Tnfr1 mice were deficient for endogenous TNFR1
but expressed IkBaSR and TNFR1 as transgenes in epidermal
keratinocytes. Whereas no skin inflammation or epidermal
hyperplasia could be detected in either K5-IkBaSR Tnfr1/ or
Tnfr1/ K5-Tnfr1 mice, the K5-IkBaSR Tnfr1/ K5-Tnfr1 mice
developed epidermal hyperplasia and inflammatory changes in
the skin within the first 3–4 days after birth, with a rapid progres-
sion resulting in the death ofmost of these animals within 10 days
(Figure S1C). Expression of transgenic TNFR1 was increased 3–
4 fold in epidermal sheets of 4-day-old Tnfr1/ K5-Tnfr1 mice
compared to expression of endogenous TNFR1 in wild-type
(WT) mice (data not shown), which might contribute to the accel-
erated kinetics of the disease in K5-IkBaSR Tnfr1/ K5-Tnfr1
mice compared to the K5-IkBaSR animals. Collectively, these
results demonstrate that keratinocyte-specific TNFR1 signaling
is both necessary and sufficient for the pathogenesis of skin
inflammation in mice with epidermis-specific NF-kB inhibition.
IL-19 and IL-24 Expression in the Epidermis Precedes
Skin Inflammation in K14-Cre Ikk2fl/fl Mice
Our results showing that TNFR1 acts in epidermal keratinocytes
to induce skin inflammation in K14-Cre Ikk2fl/fl mice suggest that
IKK2-deficient keratinocytes might produce signals triggering an
inflammatory response when stimulated by TNF. We previously
showed that myeloid cells are recruited to the skin of K14-Cre
Ikk2fl/fl mice as early as 3–4 days after birth and have an
Figure 1. TNFR1 Expression in Keratinocytes Is Necessary and Sufficient to Induce Skin Inflammation in K14-Cre Ikk2fl/fl Mice
(A) FACS analysis of TNFR1 expression in epidermal keratinocytes from mice with the indicated genotypes.
(B) Bar graph showing microscopic measurement of the epidermal thickness on skin sections obtained from mice of the indicated genotypes (n = 3). Results are
expressed as mean values ± SEM. ***p% 0.001.
(C) Histological (H&E) and immunofluorescence analysis of epidermal differentiation markers (Keratin 14, 10, 6, and loricrin) and immune cells (F4/80 and Gr-1) in
skin sections from mice with the indicated genotypes at P7. Nuclei were stained with DAPI (blue). Scale bar represents 50 mm. See also Figure S1.
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TNF-IL-24 Axis in Psoriasis-like Skin Inflammationimportant role in the pathogenesis of skin inflammation (Stratis
et al., 2006). FACS analysis of the immune cell infiltrate in the
skin of K14-Cre Ikk2fl/fl mice at P8 revealed that macrophages
(CD11b+F4/80+) and dendritic cells (CD11c+) constituted the
main immune cell populations, whereas CD3+ T lymphocytes
and neutrophils (F4/80Gr-1+) were less abundant (Figure 2A;
data not shown). We therefore reasoned that IKK2-deficient
epidermal keratinocytes might trigger skin inflammation by pro-
ducing factors attracting myeloid cells to the skin and analyzed
the expression of several cytokines and chemokines in the
epidermis of K14-Cre Ikk2fl/fl mice during the first 4 days after
birth. At P2, P3, and P4, we detected elevated transcript levels
of CCL3, CCL4, and CCL5, as well as of IL-6 and GM-CSF in
the epidermis of K14-Cre Ikk2fl/fl mice compared to their WT lit-
termates (Figures 2B and 2C). Because these proinflammatory
mediators were not upregulated at P1, we asked whether theirIproduction was preceded and perhaps induced by an initiating
factor. In an unbiased approach to detect this factor by using
microarray analysis, we identified upregulation of IL-19 and IL-
24 messenger RNA (mRNA) as early as P1 (data not shown),
which was confirmed with qRT-PCR (Figure 3A). Because the
epidermis of K14-Cre Ikk2fl/fl mice does not contain increased
numbers of myeloid cells at P1 and no expression of IL-19 and
IL-24 could be detected in dermal RNA preparations (Figure S2),
epidermal keratinocytes are the major source of the elevated
epidermal IL-19 and IL-24 mRNA. IL-19 and IL-24 were not
upregulated in the epidermis of K14-Cre Ikk2fl/fl mice at P0, sug-
gesting that their expression is induced during the first 24 hr after
birth. The increase in mRNA levels correlated with increased
production of IL-24 protein, as revealed by immunoblot analysis
of whole-skin protein lysates and by immunostaining of skin sec-
tions from K14-Cre Ikk2fl/fl and control mice (Figure 3B). IL-20mmunity 39, 899–911, November 14, 2013 ª2013 Elsevier Inc. 901
Figure 2. Upregulation of Chemokines and Proinflammatory Cytokines in the Skin of K14-Cre Ikk2fl/fl Mice
(A) FACS analysis of cells isolated from whole skin of Ikk2fl/fl and K14-Cre Ikk2fl/fl mice at P8. Bar graphs show the percentage of positive cells in relation to the
whole live-cell population (n = 3). Results are expressed as mean values ± SEM. *p% 0.05, **p% 0.01, ***p% 0.001.
(B and C) qRT-PCR analysis of chemokine (B) and cytokine (C) expression in the epidermis (P1–P4) and in whole skin (P8) of 3–8 Ikk2fl/fl and 3–8 K14-Cre Ikk2fl/fl
mice. Bars show fold regulation of chemokine and cytokine mRNA in K14-Cre Ikk2fl/fl over Ikk2fl/fl mice normalized to HPRT mRNA. All qRT-PCR results are
expressed as mean values ± SEM. *p% 0.05, **p% 0.01, ***p% 0.001.
Immunity
TNF-IL-24 Axis in Psoriasis-like Skin Inflammationand IL-22, two other members of the IL-10 cytokine family, were
upregulated in the skin at P4 and P8, but not at P2 (Figure 3C).
IL-19 and IL-24 bind to specific receptors, which signal via
STAT3 (Dumoutier et al., 2001; Parrish-Novak et al., 2002).
Consistent with the elevated expression of IL-19 and IL-24, we
detected increased nuclear staining for phosphorylated STAT3
in the epidermis of K14-Cre Ikk2fl/fl, but not of control mice at
P1, which was further increased at P3 (Figure 3D). Thus, early
upregulation of IL-19 and IL-24 correlated with STAT3 activation
in epidermal keratinocytes of K14-Cre Ikk2fl/fl mice already at P1,
a stage when no histological signs of skin inflammation can
be detected in these animals. Considering that activation of
STAT3 in keratinocytes induces psoriasis-like skin inflammation
(Sano et al., 2005), IL-19- and IL-24-mediated activation of
STAT3 in the epidermis could provide the pathogenic signal
that triggers skin inflammation in K14-Cre Ikk2fl/fl mice.
Aberrant TNFR1 Signaling Induces IL-19 and IL-24
Expression in IKK2-Deficient Keratinocytes
Because TNFR1 signaling in keratinocytes is essential for trig-
gering skin inflammation in K14-Cre Ikk2fl/fl mice, we asked
whether the upregulation of IL-19 and IL-24 in the epidermis
was induced by TNFR1. Indeed, IL-19 and IL-24 were not upre-
gulated in the epidermis of K14-Cre Ikk2fl/fl Tnfr1/ mice at P3
(Figure 4A), demonstrating that their expression was dependent902 Immunity 39, 899–911, November 14, 2013 ª2013 Elsevier Inc.on TNFR1 signaling. Consistent with these results, IL-24 upregu-
lation in the skin of K5-IkBaSRmice was also induced by TNFR1
signaling in epidermal keratinocytes (Figure 4B). Although
TNFR1 was required for the early upregulation of IL-24 in the
NF-kB-deficient epidermis, we could not detect increased TNF
mRNA in the skin of these animals during the first postnatal
days (Figure 4C; data not shown). These results indicate that
IL-24 upregulation in IKK2-deficient epidermis is not induced
by increased TNF expression but rather by an aberrant response
of keratinocytes to TNF concentrations present in normal skin.
To investigate how TNFR1 signaling induces IL-24 expression
in IKK2-deficient keratinocytes, we analyzed their response to
TNF stimulation. As shown in Figure 4D, IKK2-deficient keratino-
cytes showed increased expression of IL-24 and GM-CSF but
decreased expression of the NF-kB-dependent IL-6 gene in
response to TNF stimulation compared to control cells. This
response was specific for TNF because IL-1b stimulation did
not induce increased IL-24 and GM-CSF expression in IKK2-
deficient keratinocytes (Figure 4E). These in vitro findings
confirm that upregulation of IL-24 andGM-CSF in epidermal ker-
atinocytes of K14-Cre Ikk2fl/fl mice is the result of an aberrant
response to TNF. Because ERK activation was previously shown
to regulate IL-24 expression (Yang et al., 2011), we tested the
involvement of ERK signaling in the upregulation of IL-24 and
GM-CSF expression in IKK2-deficient keratinocytes. Inhibition
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TNF-IL-24 Axis in Psoriasis-like Skin Inflammationof MEK and ERK signaling by the specific MEK-1 and MEK-2
inhibitor UO126 suppressed the TNF-dependent expression of
IL-24 and GM-CSF in both control and IKK2-deficient keratino-
cytes (Figure 5A). In addition, IKK2-deficient keratinocytes
showed increased ERK phosphorylation after TNF stimulation
compared to control keratinocytes (Figure 5B), suggesting that
an overactivation of ERK signaling contributes to the increased
IL-24 expression in these cells. NF-kB is proposed to limit
TNF-dependent MAPK activation by inhibiting the accumulation
of reactive oxygen species (ROS) (Sakon et al., 2003). Indeed,
IKK2-deficient keratinocytes had increased concentrations of
ROS compared to control cells (Figure 5C), and treatment with
the ROS scavenger N-acetylcysteine (NAC) strongly inhibited
both TNF-induced ERK phosphorylation and IL-24 expression
in IKK2-deficient and control keratinocytes (Figures 5B and
5D). Thus, TNF-induced IL-24 expression requires ROS-medi-
ated activation of MEK and ERK signaling.
Pathogenic Role of IL-24 in the Pathogenesis of
Psoriasis-like Skin Inflammation inK14-Cre Ikk2fl/flMice
The early TNF-dependent upregulation of IL-19 and IL-24 in the
epidermis of K14-Cre Ikk2fl/fl mice identifies them as probable
proinflammatory triggers. IL-19 and IL-24 signal via distinct het-
erodimeric receptors. The IL-19 receptor, which is also used
by IL-20 and IL-24, consists of IL-20R1 and IL-20R2 chains
(Dumoutier et al., 2001). In addition, IL-24 mainly signals via
the IL-22R1 and IL-20R2 heterodimer. The IL-22R1 chain forms
an additional heterodimeric receptor with IL-10R2 that is essen-
tial for signaling by IL-22 (Sabat, 2010). To assess IL-24 and
IL-19 function in the pathogenesis of the observed skin inflam-
mation, we crossed the K14-Cre Ikk2fl/fl mice with mice deficient
for IL-20R1 (Il20ra/) or IL-22R1 (Il22ra1/). IL-20R1 deficiency
resulted in a delayed onset and decelerated development of the
skin lesions in K14-Cre Ikk2fl/fl mice. Double-deficient Il20ra/
K14-Cre Ikk2fl/fl mice showed macroscopically visible patches
of inflamed skin at P8 (data not shown); however, the skin inflam-
mation was milder as indicated by a mildly reduced epidermal
thickness compared to K14-Cre Ikk2fl/fl mice (Figure 6). More-
over, unlike K14-Cre Ikk2fl/fl animals, these mice did not die by
P8, but the skin lesions progressed to severe skin inflammation
requiring sacrificing the animals by P25.
IL-22R1 deficiency had a stronger protective effect in K14-Cre
Ikk2fl/fl mice, with double-deficient Il22ra1/ K14-Cre Ikk2fl/fl
mice showing only very few flaky patches on the skin by P8,
which covered about 3%–10% of the total visible body surface
area (data not shown). Immunohistological analysis confirmed
that most of the skin area in 8-day-old Il22ra1/ K14-Cre Ikk2fl/fl
mice did not show signs of inflammation, with normal K14, K10,
and K6 expression and an absence of immune cell infiltration
(Figure 6). The affected areas (3%–10%) of the skin of Il22ra1/
K14-Cre Ikk2fl/fl mice showed epidermal hyperplasia, deregula-
tion of keratin expression, and infiltration of immune cells, a
similar but much milder phenotype compared to the skin lesions
of K14-Cre Ikk2fl/fl mice (data not shown). Consistent with the
improved clinical signs of skin inflammation, quantification of
the epidermal thickness showed strongly reduced epidermal
hyperplasia in Il22ra1/ K14-Cre Ikk2fl/fl compared to K14-Cre
Ikk2fl/fl and Il20ra/ K14-Cre Ikk2fl/fl mice at P8 (Figure 6).
Furthermore, all double-deficient Il22ra1/ K14-Cre Ikk2fl/flImice survived to adulthood, with 11 out of 14 mice showing
only verymild signs of skin inflammation up to the age of 7 weeks
(Figure S3A; data not shown). After 14 weeks, all of the Il22ra1/
K14-Cre Ikk2fl/fl mice developed cutaneous inflammation to a
variable degree, which affected their abdomen, the flanks, and
the throat. Therefore, whereas ablation of IL-20R1 had a mild
protective effect, IL-22R1 deficiency strongly inhibited, although
it did not completely prevent, the development of inflammatory
skin lesions in the K14-Cre Ikk2fl/fl mice.
To address the potential role of IL-22, which also signals via
IL-22R1 (Sabat, 2010), we crossed the K14-Cre Ikk2fl/fl mice to
IL-22-deficient mice (Kreymborg et al., 2007). Il22/ K14-Cre
Ikk2fl/fl mice developed severe inflammatory skin lesions and
died before P9 similarly to K14-Cre Ikk2fl/fl mice, demonstrating
that IL-22 does not play an important pathogenic role in this
model (Figure S3B).
The TNF-IL-24 Axis in Human Psoriasis
Overactivation of ERK and STAT3 signaling have been reported
in psoriatic epidermis (Haase et al., 2001; Sano et al., 2005;
Takahashi et al., 2002; Wolk et al., 2009a), suggesting that the
mechanism triggering skin inflammation in K14-Cre Ikk2fl/fl
mice could be relevant for human psoriasis. As shown previously
and similar toK14-Cre Ikk2fl/fl epidermis (see Figures 2 and 3), we
found that several cytokines and chemokines were upregulated
in psoriatic epidermis, including IL-24, IL-19, IL-6, IL-1b, GM-
CSF, and CCL4 (Figures 7A and 7B). In addition, consistent
with our findings in K14-Cre Ikk2fl/fl skin, TNF transcripts were
upregulated in whole skin, but not in the epidermis of human
psoriasis lesions (Figures 7A and 7B). To investigate whether
the upregulation of IL-24 in human psoriatic epidermis could
also be induced by an aberrant signaling response of human ker-
atinocytes to TNF, we examined TNF-induced IL-24 expression
in primary human keratinocytes treated with a highly specific
IKK2 inhibitor, BI605906 (Clark et al., 2011). Similar to IKK2-defi-
cient murine keratinocytes, primary human keratinocytes
showed increased expression of IL-24 mRNA and protein upon
stimulation with TNF when pretreated with BI605906 (Figure 7C).
Therefore, inhibition of IKK2-mediated NF-kB activation led to
increased IL-24 expression in response to TNF stimulation in
both mouse and human primary keratinocytes.
To examine whether IL-24 expression in psoriatic epidermis is
driven by TNF, we measured IL-24 mRNA in the skin of psoriasis
patients before and after treatment with anti-TNF antibodies.
Anti-TNF therapy almost completely suppressed IL-24 expres-
sion in psoriatic skin, suggesting that IL-24 production is mainly
driven by TNF in psoriasis (Figure 7D). To test whether IL-24 is
capable to induce the expression of proinflammatory genes in
human epidermis, we used a three dimensional (3D) human
skin culture system (reconstituted human epidermis, RHE). As
shown in Figure 7E, IL-24 stimulation induced the expression
of many of the inflammatory mediators detected in psoriasis,
including psoriasin, LCN2, IL-20, CXCL1, CXCL8, and CCL20.
An increase in epidermal thickness was also observed in IL-24
stimulated compared to unstimulated RHE (Figure S4). Taken
together, our results suggest that TNF-driven IL-24 expression
in keratinocytes contributes to the induction of inflammation in
psoriasis, similar to our findings in the K14-Cre Ikk2fl/fl mouse
model.mmunity 39, 899–911, November 14, 2013 ª2013 Elsevier Inc. 903
Figure 3. Upregulation of IL-19 and IL-24 and Activation of STAT3 in the Epidermis of K14-Cre Ikk2fl/fl Mice
(A) qRT-PCR analysis of IL-19 and IL-24 expression in whole skin (P8) or epidermal extracts (P1–P4) of Ikk2fl/fl and K14-Cre Ikk2fl/fl mice.
(B) Immunoblot and immunohistochemical analysis of IL-24 expression in the skin of Ikk2fl/fl and K14-Cre Ikk2fl/fl (IKK2E-KO) mice with specific antibodies. Actin
served as loading control. Red signal in immunostaining shows IL-24. Scale bar represents 50 mm.
(legend continued on next page)
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Figure 4. TNF-Dependent Regulation of IL-19, IL-24, and GM-CSF Expression in IKK2-Deficient Epidermal Keratinocytes
(A–C) qRT-PCR analysis of expression of IL-19 and IL-24 in the epidermis of K14-Cre Ikk2fl/fl and Ikk2fl/fl mice each at P3 (A), IL-24 expression in the skin of
Tnfr1/K5-Tnfr1 andK5-IkBaSR Tnfr1/K5-Tnfr1mice at P4 (B), and TNF expression in the whole skin ofK14-Cre Ikk2fl/fl and Ikk2fl/fl mice at P2, P4, and P6 (C).
Bars show fold regulation of TNF, IL-19, and IL-24 inK14-Cre Ikk2fl/fl,K14-Cre Ikk2fl/fl Tnfr1/, and K5-IkBaSR Tnfr1/K5-Tnfr1mice over the respective control
mice normalized to HPRT mRNA.
(D and E) qRT-PCR analysis of cytokine expression in primarymurine keratinocytes isolated from Ikk2fl/fl (gray bars) andK14-Cre Ikk2fl/fl (black bars) mice 6 hr after
stimulation with 100 ng/ml rmTNF (D) or 20 ng/ml IL-1b (E). Bars show fold regulation in IKK2-deficient keratinocytes over the respective unstimulated control
keratinocytes normalized to HPRT mRNA. All qRT-PCR results are expressed as mean values ± SEM. *p% 0.05, ***p% 0.001.
Immunity
TNF-IL-24 Axis in Psoriasis-like Skin InflammationDISCUSSION
Our results presented here unravel a keratinocyte-intrinsic
mechanism triggering psoriasis-like skin inflammation in mice
with epidermis-specific NF-kB inhibition that is relevant for the
understanding of the pathogenesis of psoriatic skin inflammation
in humans. We show that TNFR1 signaling in IKK2-deficient
epidermal keratinocytes is both necessary and sufficient for
the development of skin inflammation, identifying skin epithelial
cells as the major cellular target of the pathogenic TNF signals
in this model. In addition, we identify TNFR1-induced, ROS-,
and ERK-dependent expression of IL-24 in keratinocytes as a
key early event contributing to skin inflammation. Our genetic ex-
periments showing that IL-22R1 deficiency strongly ameliorated
skin inflammation in K14-Cre Ikk2fl/fl mice provide functional
evidence for the key role of IL-24 as an early upstream cytokine
inducing skin inflammation in this model. This is further sup-
ported by our findings that IL-20 and IL-22, which also signal(C) qRT-PCR analysis of IL-20 and IL-22 expression in whole skin (P2, P4, and P
(D) Representative images (left) and quantification (right) of immunofluorescence s
Cre Ikk2fl/fl mice at P1 and P3. Nuclei were stained with PI (red). Scale bar represen
**p% 0.01, ***p% 0.001. See also Figure S2.
Ivia IL-22R1, were not upregulated at early stages of phenotype
development. Indeed, IL-22 deficiency did not affect skin lesion
development in these mice. However, although its expression
pattern argues against a critical role in the initiation of skin inflam-
mation in K14-Cre Ikk2fl/fl mice, in the absence of functional
evidence we cannot exclude that IL-20 also contributes to lesion
development. Our findings are in line with recent results showing
that transgenic expression of IL-24 in mouse epidermis was
sufficient to induce skin inflammation (He and Liang, 2010). In
addition, the very mild protective effect of IL-20R1-deficiency
suggests that IL-19, which signals exclusively via this receptor,
is unlikely to play an important role in this type of skin inflamma-
tion, consistent with the findings that transgenic mice over-
expressing IL-19 in the epidermis did not develop skin lesions
(Parrish-Novak et al., 2002).
What is the relevance of our mouse model findings for the
pathogenesis of human psoriasis? As shown recently (Wang
et al., 2012), we also found that IL-24, together with IL-19, was8) of Ikk2fl/fl and K14-Cre Ikk2fl/fl mice.
taining for phosphorylated STAT-3 (green) on skin sections of Ikk2fl/fl and K14-
ts 50 mm. All qRT-PCR results are expressed asmean values ± SEM. *p% 0.05,
mmunity 39, 899–911, November 14, 2013 ª2013 Elsevier Inc. 905
Figure 5. TNF-Induced Expression of IL-24 and GM-CSF in Keratinocytes Depends on ROS and MEK-ERK Signaling
qRT-PCR analysis of IL-24 and GM-CSF expression (A, D), as well as ELISA of GM-CSF protein (A), measurement of ROS production (C), and immunoblot
analysis of p44 and p42 phosphorylation after TNF stimulation with or without NAC (B) in primary epidermal keratinocytes isolated from Ikk2fl/fl andK14-Cre Ikk2fl/fl
mice. qRT-PCR analysis was performed with RNA obtained 6 hr after stimulation and ELISA on supernatants harvested 8 hr after stimulation of cells with
100 ng/ml rmTNF in the presence or absence of the MEK inhibitor UO126 (1 mM) or NAC (10 mM) as indicated. Bar graphs show fold regulation of cytokine
expression in TNF-stimulated Ikk2fl/fl and K14-Cre Ikk2fl/fl keratinocytes in the presence or absence of UO126 or NAC over vehicle-stimulated keratinocytes from
the same isolate, respectively. Constitutive ROS production in primary keratinocytes isolated from Ikk2fl/fl and K14-Cre Ikk2fl/fl keratinocytes were measured with
the fluorescent dye CM-H2DCFDA. All data are expressed as mean values ± SEM of two different isolates of primary keratinocytes. *p% 0.05, **p% 0.01.
Immunity
TNF-IL-24 Axis in Psoriasis-like Skin Inflammationupregulated in psoriatic epidermis, similarly to the K14-Cre
Ikk2fl/fl and K5-IkBaSR mice. In addition, our results showing
that pharmacological inhibition of IKK2-mediated NF-kB activa-
tion strongly increased TNF-induced IL-24 expression in primary
human keratinocytes suggest that the TNF-dependent mecha-
nism triggering skin inflammation in our mouse models is rele-
vant for humans. Consistent with a recent study showing that
anti-TNF treatment acutely suppressed the expression of IL-
19, IL-20, and IL-24 in psoriatic epidermis (Wang et al., 2012),
we also detected downregulation of IL-24 expression in the
skin of anti-TNF-treated psoriasis patients, suggesting that the
epidermal keratinocyte is an important and direct cellular target
of pathogenic TNF signaling also in human psoriasis. Our results
in a human epidermis model showing that IL-24 strongly induces
the expression of proinflammatory mediators known to be
expressed in psoriatic skin also provide experimental evidence
that IL-24 might act as an important upstream mediator in the
pathogenesis of psoriatic skin inflammation, similarly to skin
inflammation in our mouse models. There is still an ongoing
debate concerning primary pathogenic functions of epidermal
keratinocytes versus T lymphocytes in psoriasis, and there is
evidence for both cell types playing important roles in disease
development (Nickoloff et al., 2000). Previously, a possible906 Immunity 39, 899–911, November 14, 2013 ª2013 Elsevier Inc.contribution of epidermal keratinocytes to the pathogenesis of
psoriasis has been discussed primarily in the context of the dra-
matic changes in proliferation and differentiation that these cells
undergo during disease development. Our results show that, in
addition to their well-characterized role in epidermal hyperplasia,
keratinocytes exhibit a potent capacity to initiate skin inflamma-
tion and could therefore be a crucial cellular component trig-
gering the onset of the inflammatory response in psoriasis.
More recent concepts of psoriasis pathogenesis allocate func-
tions of different cell types to the changing phases of the disease
process: it is thought that disease initiation is driven by innate
immune responses, whereas T cell-dependent adaptive immune
mechanisms take control in themaintenance phase (Nestle et al.,
2009; Sabat et al., 2007). We showed previously that the disease
in K14-Cre Ikk2fl/fl mice develops independently of ab T cells
(Pasparakis et al., 2002), suggesting that this model is more rele-
vant for the innate immunity-driven initial phase of the disease.
This concept is also compatible with our results that IL-24, but
not IL-22, is critical for disease initiation. The idea of functional
redundancies between these two cytokines in the development
of psoriatic skin inflammation is tempting and is compatible
with the two-phase model of the pathogenesis of psoriatic
inflammation (Nestle et al., 2009; Sabat et al., 2007). As IL-24
Figure 6. IL-22RI-Deficiency Inhibits the Development of Skin Inflammation in K14-Cre Ikk2fl/fl Mice
Histological analysis of skin frommicewith the indicated genotypes at P8. Skin sections were stainedwith H&E or immunostainedwith antibodies against CD11b,
F4/80, CD3, Keratin 6, Keratin 14, and Keratin 10 (green). Nuclei were stained with PI (red). Scale bar represents 100 mm (H&E), 50 mm (immunemarker stainings),
and 40 mm (keratin stainings). Bar graph in the lower panel shows microscopic measurement of the epidermal thickness on skin sections obtained from mice of
the indicated genotypes (n = 3–4). Results are expressed as mean values ± SEM. *p% 0.05, **p% 0.01, ***p% 0.001. See also Figure S3.
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TNF-IL-24 Axis in Psoriasis-like Skin Inflammationis mainly produced by epithelial and innate immune cells and IL-
22 by T- lymphocytes (Conti et al., 2003; Kunz et al., 2006;
Ouyang et al., 2011; Zheng et al., 2007), it is conceivable that
IL-24 is particularly relevant for the initiation phase, whereas
IL-22 could be mainly involved in the chronic phase of the dis-
ease. We therefore consider our mouse models as valuable for
understanding the mechanisms governing the initiation phase
of psoriasis-like skin inflammation.
Anti-TNF therapy is currently one of the most effective treat-
ments for psoriasis; however, the TNF-dependent mechanisms
causing psoriatic inflammation are unknown. Our results suggest
that epidermal keratinocytes are critical targets of pathogenic
TNF signaling in psoriasis. Unexpectedly, it is not the upregula-
tion of TNF expression but rather the deregulation of TNFR1
signaling that provides the pathogenic signal. In addition to
NF-kB inhibition, other alterations disturbing TNF-TNFR1
signaling in epidermal keratinocytes also induced skin inflam-
mation. For example, epidermis-specific FADD deficiency
sensitizes keratinocytes to TNF-induced RIP kinase 3 (RIPK3)-
mediated necrosis and spontaneously triggers severe skin
inflammation in mice (Bonnet et al., 2011). Given that a TNF-
TNFR1-dependent surveillance mechanism is present in normal,
resting skin, any intracellular change leading to altered TNFR1Isignaling responses in epidermal keratinocytes could trigger
the initiation of skin inflammation. This TNF-dependent surveil-
lancemechanism could have an important physiological function
to ensure the rapid induction of skin inflammation that is essen-
tial for host defense, wound healing, and tissue regeneration.
The development of psoriatic lesions after wounding of the
skin is a typical clinical characteristic of the disease known as
Koebner phenomenon and could be explained by such a mech-
anism. Many polymorphisms that have been associated with
psoriasis in genome-wide association studies lie within genes
encoding proteins of the TNF-NF-kB signaling pathway or asso-
ciated regulatory proteins (Jordan et al., 2012; Nair et al., 2009).
Although the functional consequences of these genetic polymor-
phisms are largely unknown, it is conceivable that some of these
alleles could contribute to skin inflammation by altering TNFR
signaling in epidermal keratinocytes.
Considering that chronic skin inflammation clinically identified
as psoriasis most likely represents a range of diseases with
distinct etiologies, it is likely that different mechanisms affecting
the response of epidermal keratinocytes to TNF and most likely
other immune surveillance mechanisms could trigger the
disease. Indeed, previous studies showed that disturbance of
different signaling pathways in keratinocytes can induce skinmmunity 39, 899–911, November 14, 2013 ª2013 Elsevier Inc. 907
Figure 7. TNF-Induced IL-24 Expression by Epidermal Keratinocytes Is Relevant for Human Psoriasis
(A and B) qRT-PCR analysis of the expression of the indicated cytokines and chemokines in whole skin (A, n = 8–11) and epidermis (B, n = 3–5) from normal or
psoriatic skin samples. Graphs show arbitrary gene expression relative to HPRT.
(C) Left shows human primary keratinocytes (n = 3) that were stimulated for 6 hr with 100 ng/ml TNF in the presence or absence of the IKK2 inhibitor Bl605906
(5 mM) and IL-24mRNA levels that were determined by qRT-PCR. Graphs show fold regulation compared to unstimulated cells normalized to HPRTmRNA. Right
shows human primary keratinocytes (n = 4) that were stimulated for 48 hr with 10 ng/ml TNF in the presence or absence of the IKK2 inhibitor Bl605906 (5 mM). IL-24
concentrations in culture supernatants were determined by ELISA. Data are shown as mean values ± SEM.
(D) qRT-PCR analysis of IL-24 expression in skin before (0) and 12 and 24 weeks after anti-TNF treatment. Bars show percentage of IL-24 expression in anti-TNF
treated skin after 12 weeks and 24 weeks over 0 weeks.
(E) qRT-PCR analysis of the expression of the indicated cytokines and chemokines in reconstituted human epidermis (n = 6) 72 hr after stimulation with IL-24
(20 ng/ml). Bars show percentage of mRNA expression in IL-24 stimulated over unstimulated 3D epidermis normalized to HPRTmRNA. Results are expressed as
mean values ± SEM. *p% 0.05, **p% 0.01, ***p% 0.001. See also Figure S4.
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Immunity
TNF-IL-24 Axis in Psoriasis-like Skin Inflammationinflammation, including activation of NF-kB (Rebholz et al.,
2007), MEK1/ERK (Hobbs et al., 2004; Hobbs and Watt, 2003),
or STAT3 signaling (Sano et al., 2005) and also inhibition of
Jun-AP1 signaling (Zenz et al., 2005). Because all of these path-
ways are involved in the regulation of keratinocyte reactions to
stress, infection, or injury, it is tempting to hypothesize that
deregulation of normal keratinocyte responses to environmental
challenges could be amajor pathogenic factor triggering the initi-
ation of psoriatic inflammation. By identifying a keratinocyte-
intrinsic mechanism that links TNF, NF-kB, ERK, and STAT3
signaling with the initiation of psoriasis-like skin inflammation,
our results provide an important step toward the better under-
standing of the pathogenesis of psoriasis.
EXPERIMENTAL PROCEDURES
Mice
The following mouse lines were used: Ikk2FL (Pasparakis et al., 2002), K14-Cre
(Hafner et al., 2004; Pasparakis et al., 2002), Tnfr1/ (Pfeffer et al., 1993),
Tnfr1cneo (Victoratos et al., 2006), K5-IkBaSR (van Hogerlinden et al., 1999),
Il22/ (Kreymborg et al., 2007), and Tnfr1FL (Van Hauwermeiren et al.,
2013). IL-20R1 and IL-22R1 knockout mice will be described elsewhere. All
animal procedures were conducted in accordance with European, national,
and institutional guidelines, and protocols and were approved by local govern-
mental authorities.
Immunostainings
Keratin staining on paraffin sections and CD11b, F4/80, Gr-1, CD3, and STAT-
3 staining on cryosections were performed as described (Stratis et al., 2006).
IL-24 staining was performed on cryosections with anti-IL-24 antibodies
(Santa Cruz Biotechnology). Details of the procedures are provided under Sup-
plemental Experimental Procedures.
Isolation, Culture, and Stimulation of Keratinocytes
Primary epidermal keratinocytes were isolated from newborn mice and
cultured as described before (Tscharntke et al., 2007). Primary human
epidermal keratinocytes were obtained from Cascade Biologics and Promo-
cell and cultured in KGM Gold Medium (Lonza). Cells were starved overnight
in 1% FCS containing medium before stimulation with TNF or IL-1b. Inhibitors
UO126 (EMD, Calbiochem), N-Acetyl-L-Cysteine (Sigma Aldrich), or Bl605906
(Clark et al., 2011) were added 1 hr prior to cell stimulation.
Reconstituted Human Epidermis Culture and Stimulation
Underdeveloped EpiDerm-201 reconstituted human epidermis (RHE) tissues
composed of stratified human keratinocytes derived from neonatal foreskins
were obtained from MatTek and were cultured as described previously
(Wolk et al., 2011). Briefly, they were cultured in inserts at the air-liquid inter-
face with hydrocortisone-free Epi-201-DM differentiation medium (MatTek).
For stimulation, culture medium was supplemented or not (control) with
20 ng/ml IL-24 (R&D Systems). After 72 hr, biopsies were taken from the
tissues and either snap-frozen for histology (determination of thickness of
the living cell layers) or lysed for mRNA analysis.
Separation of Epidermis, RNA Isolation, and cDNA Synthesis
Human tissue samples and cells were used after approval by the Ethics Com-
mittee of theMedical Faculty of Cologne University and the clinical institutional
review board of the University Medicine Charite´, Berlin. Punch skin biopsies
were obtained from adult control participants (30 to 67 years old) and patients
with plaque psoriasis (26 to 63 years old, ca. 65%moderate to severe disease).
Mouse and human epidermis were peeled off after incubating skin samples in
0.5 M ammonium thiocyanate (NH4SCN) in phosphate buffer, pH 6.8 (0.1 M
NH2HPO4, 0.1 M KH2PO4) for 30 min on ice. Total RNA was extracted from
homogenized tissue or cultured keratinocytes with TRIzol reagent (Invitrogen)
and purified with an RNeasy mini kit (QIAGEN, Hilden) or Invisorb RNA kit II
(Invitek/Stratec molecular GmbH) as per manufacturer’s protocol. Single-
stranded cDNA was synthesized from 1 mg of total RNA with the cDNA synthe-Isis kit (Applied Biosystems, Thermo Fisher/Fermentas or Life Technologies/
GIBCO) according to the manufacturer’s instructions.
Quantitative Real-Time PCR
Quantitative real-time PCR was performed on cDNA with Power SYBR Green
PCR mix (Applied Biosystems) or Maxima Probe/ROX qPCR Master Mix
(Thermo Fisher Scientific/Fermentas) and systems with double-labeled fluo-
rescent probes as described previously (Wolk et al., 2004) with a 7300 or Ste-
pOnePlus Real Time PCR system (Applied Biosystems). Details of the analysis
and primer sequences (Tables S1 and S2) are provided under Supplemental
Experimental Procedures.
Immunoblot
Tissue and cell lysates were resolved on SDS PAGE and probed with primary
antibodies, and immunoreactive proteins were visualized with HRP-coupled
secondary antibodies and chemiluminescence reagents (PerkinElmer; Pierce
Thermo Fisher Scientific) on an Uvichemi chemiluminescence documentation
system (Biometra). Details of the method are provided under Supplemental
Experimental Procedures.
Statistical Analysis
Statistical significance between in vivo-derived samples and in vitro-generated
sampleswith different genotypeswasdeterminedwith the unpairedStudent’s t
test or theMann-Whitney U-test (two-tailed) (*p < 0.05, **p < 0.01, ***p < 0.001).
Paired in vitro generated samples were tested for significant differences
between treatment groups with the Wilcoxon matched-pairs signed- rank
test or paired student t test (two-tailed) (*p% 0.05, **p < 0.01, ***p < 0.001).
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.immuni.2013.10.009.
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